EUVIMEDEUVIMED entdecken
Crossref

Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy

Sophie L V M Stroeks iD, Ida G Lunde iD, Debby M E I Hellebrekers, Godelieve R F Claes iD, Hiroko Wakimoto iD, Joshua Gorham iD, Ingrid P C Krapels iD, Els K Vanhoutte, Arthur van den Wijngaard, Michiel T H M Henkens iD, Anne G Raafs iD, Maurits A Sikking und 6 weitere

Circulation: Genomic and Precision Medicine · 2023-04 · 16 (2)

DOI: 10.1161/circgen.122.003788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2023-04. Verfasst von Sophie L V M Stroeks und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute Maastricht (CARIM); S.L.V.M.S., T.H.M.H., A.G.R., M.A.S., E.A.V.J., S.R.B.H., J.A.J.V.), Maastricht University, Maa…. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dilated cardiomyopathy (DCM) was considered a monogenetic disease that can be caused by over 60 genes. Evidence suggests that the combination of multiple pathogenic variants leads to greater disease severity and earlier onset. So far, not much is known about the prevalence and disease course of multiple pathogenic variants in patients with DCM. To gain insight into these knowledge gaps, we (1) systematically collected clinical information from a well-characterized DCM cohort and (2) created a mouse model.

Methods

Complete cardiac phenotyping and genotyping was performed in 685 patients with consecutive DCM. Compound heterozygous digenic (LMNA [lamin]/titin deletion A-band) with monogenic (LMNA/wild-type) and wild-type/wild-type mice were created and phenotypically followed over time.

Results

One hundred thirty-one likely pathogenic/pathogenic (LP/P) variants in robust DCM-associated genes were found in 685 patients with DCM (19.1%) genotyped for the robust genes. Three of the 131 patients had a second LP/P variant (2.3%). These 3 patients had a comparable disease onset, disease severity, and clinical course to patients with DCM with one LP/P. The LMNA/Titin deletion A-band mice had no functional differences compared with the LMNA/wild-type mice after 40 weeks of follow-up, although RNA-sequencing suggests increased cardiac stress and sarcomere insufficiency in the LMNA/Titin deletion A-band mice.

Conclusions

In this study population, 2.3% of patients with DCM with one LP/P also have a second LP/P in a different gene. Although the second LP/P does not seem to influence the disease course of DCM in patients and mice, the finding of a second LP/P can be of importance to their relatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedHumansAnimalsMiceConnectinPrevalenceMutationGenotype

Stichwörter der Autor:innen

cardiomyopathydilatedgenotypephenotype

Substanzen

Connectin

Autor:innen und Institutionen

  • Cardiovascular Research Institute Maastricht (CARIM); S.L.V.M.S., T.H.M.H., A.G.R., M.A.S., E.A.V.J., S.R.B.H., J.A.J.V.), Maastricht University, Maastricht, Netherlands.
  • KU Leuven, Cardiovascular Sciences, Belgium (S.L.V.M.S., E.A.V.J., S.R.B.H.).
  • Genetics, Harvard Medical School, Boston, MA (I.G.L., H.W., J.G.).
  • Diagnostics and Technology, Akershus University Hospital, Oslo, Norway (I.G.L.).
  • Clinical Genetics, Maastricht University Medical Center, the Netherlands (D.M.E.I.H., G.R.F.C., I.P.C.K., E.P.K., A.v.d.W., H.G.B., J.A.J.V.).
  • Genetics and Cell Biology (J.L.V.B., M.N.), Maastricht University, Maastricht, Netherlands.

ORCID-Profile: Sophie L V M Stroeks, Ida G Lunde, Godelieve R F Claes, Hiroko Wakimoto, Joshua Gorham, Ingrid P C Krapels, Michiel T H M Henkens, Anne G Raafs, Elizabeth A V Jones, Stephane R B Heymans, Han G Brunner, Job A J Verdonschot

Zitieren

APA

Stroeks, S. L. V. M., Lunde, I. G., Hellebrekers, D. M. E. I., Claes, G. R. F., Wakimoto, H., Gorham, J., Krapels, I. P. C., Vanhoutte, E. K., van den Wijngaard, A., Henkens, M. T. H. M., Raafs, A. G., Sikking, M. A., Broers, J. L. V., Nabben, M., Jones, E. A. V., Heymans, S. R. B., Brunner, H. G., & Verdonschot, J. A. J. (2023). Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy. Circulation: Genomic and Precision Medicine, 16(2). https://doi.org/10.1161/circgen.122.003788

Vancouver

Stroeks SLVM, Lunde IG, Hellebrekers DMEI, Claes GRF, Wakimoto H, Gorham J, et al. Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy. Circulation: Genomic and Precision Medicine. 2023;16(2). doi:10.1161/circgen.122.003788

BibTeX
@article{Stroeks2023,
  author = {Stroeks, Sophie L V M and Lunde, Ida G and Hellebrekers, Debby M E I and Claes, Godelieve R F and Wakimoto, Hiroko and Gorham, Joshua and Krapels, Ingrid P C and Vanhoutte, Els K and van den Wijngaard, Arthur and Henkens, Michiel T H M and Raafs, Anne G and Sikking, Maurits A and Broers, Jos L V and Nabben, Miranda and Jones, Elizabeth A V and Heymans, Stephane R B and Brunner, Han G and Verdonschot, Job A J},
  title = {Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2023},
  volume = {16},
  number = {2},
  doi = {10.1161/circgen.122.003788}
}
Kostenlos starten →